Emmanuelle Andree Danielle Schindler MD PhD
Headache
Neurology Service Attending, West Haven VA Medical Center; Assistant Professor of Neurology, Yale School of Medicine
Join to View Full Profile
950 Campbell AveWest Haven, CT 06516
Phone+1 203-932-5711
Fax+1 203-937-3464
Dr. Schindler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Veterans Affairs Connecticut Healthcare SystemFellowship, 2016 - 2018
Yale-New Haven Medical CenterResidency, Neurology, 2013 - 2016- Yale-New Haven Medical CenterResidency, Internal Medicine, 2012 - 2013
Drexel University College of MedicineClass of 2012
Certifications & Licensure
CT State Medical License 2016 - 2025
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Psilocybin for the Treatment of Cluster Headache Start of enrollment: 2016 Dec 05
- Psilocybin for the Treatment of Migraine Headache Start of enrollment: 2017 Nov 01
- Effects of Psilocybin in Concussion Headache Start of enrollment: 2019 Mar 28
Publications & Presentations
PubMed
- The Pain Gap: Epistemic Justice in Psychedelic Ethics.Joanna Kempner, Emmanuelle A D Schindler
The American Journal of Bioethics. 2025-01-01 - 1 citationsCharacteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study.Elizabeth K Seng, Mark J Burish, Brenda T Fenton, Emmanuelle A D Schindler, Bin Zhou
Headache. 2024-10-14 - 1 citationsManaging Cluster Headache in Patients with Medical, Psychiatric, and Surgical Comorbidities.Mark J Burish, Alexander B Guirguis, Emmanuelle A D Schindler
Current Neurology and Neuroscience Reports. 2024-09-01
Press Mentions
The Psychedelic Remedy for Chronic PainOctober 1st, 2022- Why Magic Mushrooms Are Emerging as Major Part of Public Discourse: What Science Is SayingSeptember 23rd, 2022
- electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic HeadacheMay 4th, 2021
- Join now to see all
Research History
- Advanced Research FellowIn my fellowship at VA Connecticut Healthcare System, I developed and executed the first controlled human trials of psilocybin in headache disorders (and any neurological disorder).2016 - 2018
- Graduate studentAs a graduate student at Drexel, I studied the neuropharmacology of 5-hydroxytryptamine (5-HT)2A receptor compounds, outlining biochemical and behavioral effects in the context of receptor binding and intracellular signaling.2005 - 2010
Professional Memberships
- Member
- American Headache SocietyMember
- Headache Cooperative of New EnglandMember
- International Society for Research on PsychedelicsMember
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
